Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial User worldnewsbot, in the News From Around The World subreddit, 18 Mar 2018
Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial User ShyExtrovert_, in the /r/trees - home of the ents subreddit, 18 Mar 2018
“Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syndrome and is generally well tolerated. The long-term efficacy and safety of cannabidiol is currently being assessed in the open-label extension of this trial.” User Ro-bird-a, in the CBD: The Medical Marijuana and Hemp Cannabinoid Community subreddit, 17 Mar 2018
Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial User SirT6, in the Reddit Science subreddit, 17 Mar 2018